Staphylococcus-induced proliferative glomerulonephritis and cerebral hemorrhage – fatal complications in a young female with postpartum cardiomyopathy and an implanted left ventricular assist device: a case report and review of the literature

References

• Laghari AH, Khan AH, Kazmi KA. Peripartum cardiomyopathy: ten year experience at a tertiary care hospital in Pakistan . BMC Res Notes. 2013;6:495.
   PubMedGoogle Scholar
• Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–670.
   PubMed Web of Science ®Google Scholar
• Johnson-Coyle L, Jensen L, Sobey A. Peripartum cardiomyopathy: review and practice guidelines. Am J Crit Care. 2012;21(2):89–98.
   PubMed Web of Science ®Google Scholar
• Gupta D, Wenger NK. Peripartum cardiomyopathy: status 2018. Clin Cardiol. 2018;41(2):217–219.
   PubMed Web of Science ®Google Scholar
• Oosterom L, de Jonge N, Kirkels JH, et al. Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy. Neth Heart J. 2008;16(12):426–428.
   PubMed Web of Science ®Google Scholar
• Tariq Y, Ziffra J, Kramer J, et al. Mechanical circulatory support for peripartum cardiomyopathy. J Med Cases. 2015;6(5):219–220.
   Google Scholar
• Parikh U, Lamba H, Ajmal M, et al. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021;24(2):207–216.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34(12):1495–1504.
   PubMed Web of Science ®Google Scholar
• Jezovnik MK, Gregoric ID, Poredos P. Medical complications in patients with LVAD devices. e-J Cardiol Pract. 2017;14:37.
   Google Scholar
• Stomp W. HeartWare ventricular assist system receives FDA approval as bridge to heart transplantation. [cited 2022 Jan 18]. https://www.medgadget.com/2012/11/heartware-ventricular-assist-system-receives-fda-approval-as-bridge-to-heart-transplantation-video.html
   Google Scholar
• Pagani D, Gago O. Medicine recent trials with durable LVADs: is there a superior device? [cited 2022 Jan 18]. https://www.aats.org/aatsimis/SiteDownloads/MCS18/Thursday%20pdf/Plenary_0810%20Pagani.pdf.
   Google Scholar
• Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–1084.
   PubMed Web of Science ®Google Scholar
• Davis MB, Arany Z, McNamara DM, et al. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(2):207–221.
   PubMed Web of Science ®Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–1443.
   PubMed Web of Science ®Google Scholar
• Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, et al. The society of thoracic surgeons intermacs database annual report: evolving indications, outcomes, and scientific partnerships. Ann Thorac Surg. 2019;107(2):341–353.
   PubMed Web of Science ®Google Scholar
• Ramey WL, Basken RL, Walter CM, et al. Intracranial hemorrhage in patients with durable mechanical circulatory support devices: institutional review and proposed treatment algorithm. World Neurosurg. 2017;108:826–835.
   PubMed Web of Science ®Google Scholar
• Cho SM, Moazami N, Frontera JA. Stroke and intracranial hemorrhage in HeartMate II and HeartWare left ventricular assist devices: a systematic review. Neurocrit Care. 2017;27(1):17–25.
   PubMed Web of Science ®Google Scholar
• Hasin T, Matsuzawa Y, Guddeti RR, et al. Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events. Circ J. 2015;79(4):770–777.
   PubMed Web of Science ®Google Scholar
• Hisamatsu E, Seguchi O, Okada N, et al. Gynecological complications in female patients with left ventricular assist device support. J Heart Lung Transplant. 2016;35:132.
   Google Scholar
• Wever-Pinzon O, Selzman CH, Drakos SG, et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circulation Heart Failure. 2013;6:517–526.
   PubMed Web of Science ®Google Scholar
• Yavar Z, Cowger JA, Moainie SL, et al. Bleeding complication rates are higher in females after continuous-flow left ventricular assist device implantation. ASAIO J. 2018;64(6):748–753.
   PubMed Web of Science ®Google Scholar
• Etz C, Welp H, Scheld HH, et al. Near fatal infection of a patient with a left ventricular assist device due to unrecognized fetal death. Eur J Cardiothorac Surg. 2005;27(4):722–723.
   PubMed Web of Science ®Google Scholar
• Crow S, Chen D, Milano C, et al. Acquired Von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90(4):1263–1269.
   PubMed Web of Science ®Google Scholar
• Yoshioka D, Okazaki S, Toda K, et al. Prevalence of cerebral microbleeds in patients with continuous‐flow left ventricular assist devices. J am heart assoc. 2017;6:e005955.
   PubMed Web of Science ®Google Scholar
• Uzarski JS, Scott EW, McFetridge PS. Adaptation of endothelial cells to physiologically-modeled, variable shear stress. PLoS One. 2013;8(2):e57004.
   PubMed Web of Science ®Google Scholar
• Tabit CE, Chen P, Kim GH, et al. Elevated angiopoietin‐2 level in patients with continuous‐flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding. Circulation. 2016;134(2):141–152.
   PubMed Web of Science ®Google Scholar
• Opriş EC, Suciu H, Jung I, et al. Mesangioproliferative glomerulonephritis with extracapillary crescents - unexpected fatal complication in a 17-year-old patient with implanted left ventricular assist device. Rom J Morphol Embryol. 2020;61(2):535–544.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Gupta A, Kumar S, et al. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device? ASAIO J. 2012;58(5):509–513.
   PubMed Web of Science ®Google Scholar
• Willey JZ, Boehme AK, Castagna F, et al. Hypertension and stroke in patients with Left Ventricular Assist Devices (LVADs). Curr Hypertens Rep. 2016;18(2):12.
   PubMed Web of Science ®Google Scholar
• Saritas T, Brandenburg V, Federico G, et al. Glomerulonephritis triggered by a chronically infected left ventricular assist device. Lancet. 2015;386(10010):2363–2364.
   PubMed Web of Science ®Google Scholar
• Pasrija C, Tran D, George P, et al. Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency. J Thorac Cardiovasc Surg. 2020;159(4):1307–1319.
   PubMed Web of Science ®Google Scholar
• Alraies MC, Eckman P. Adult heart transplant: indications and outcomes. J Thorac Dis. 2014;6(8):1120–1128.
   PubMed Web of Science ®Google Scholar